Joshua Fitch is an editor for Contemporary Pediatrics.
FDA approves rilpivirine for pediatric patients with HIV-1, weighing 14 kg to 25 kg
March 20th 2024Administration of the HIV-1 specific, non-nucleoside reverse transcriptase inhibitor (NNRTI) to the indicated population can be done via 25 mg oral tablets or new 2.5 mg oral tablets, developed to help administration and weight-adjusted dosing for children.
Twiist automated insulin delivery system FDA cleared for children 6 years and up with T1D
March 18th 2024Integrated data from a continuous glucose monitoring device (CGM) and an insulin pump to automate insulin delivery allow AID systems to manage patient blood sugar levels more "effectively," according to Sequel.
NAPNAP networking opportunities, navigating artificial intelligence in health care
March 14th 2024Tracie W. Kirkland, PhD, DNP, ANP-BC, PPCPNP, CPNP-BC, shares why she looks forward to networking at the 2024 NAPNAP National Conference on Pediatric Health Care, taking place from March 13-16, 2024, in Denver, Colorado.
Sessions and topics to look forward to at the 2024 NAPNAP National Conference
March 13th 2024Donna Hallas, PhD, CPNP, PPCNP-BC, PMHS, FAANP, FAAN, shares her thoughts and excitement for the 2024 NANAP National Conference on Pediatric Health Care, taking place in Denver, Colorado, from March 13-16, 2024.
Medical spending for children with mental health conditions increased 31% from 2017-2021
March 12th 2024In 2021, pediatric mental health conditions were associated with $31 billion in child spending and $59 billion in household spending, which made up 46.6% of all pediatric medical spending that year.
FDA approves alirocumab to treat HeFH patients aged 8 years and up
March 12th 2024The approval is based on data from a phase 3, multicenter, randomized trial that evaluated patients aged 8 to 17 years with HeFH who had LDL-C levels of 130 mg / dL or greater who were being treated with lipid-lowering medications.
Tapinarof cream 1% demonstrates efficacy in atopic dermatitis patients with skin of color
March 8th 2024Data from a pair of identical, phase 3, double-blind, randomized, and vehicle-controlled trials were presented at the 2024 American Academy of Dermatology (AAD) Annual Meeting in San Diego, California.
Can smartwatch technology identify arrhythmias in children with adult algorithms?
February 28th 2024Scott Ceresnak, MD, explains smartwatch technology could be a great tool in detecting arrhythmias in children, however, given that algorithms in the technology were designed for adults, caution must be used as well.